Sabina Mugusi

817 total citations
28 papers, 602 citations indexed

About

Sabina Mugusi is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Sabina Mugusi has authored 28 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 11 papers in Virology and 9 papers in Epidemiology. Recurrent topics in Sabina Mugusi's work include HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (11 papers) and HIV/AIDS Research and Interventions (6 papers). Sabina Mugusi is often cited by papers focused on HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (11 papers) and HIV/AIDS Research and Interventions (6 papers). Sabina Mugusi collaborates with scholars based in Tanzania, Sweden and Germany. Sabina Mugusi's co-authors include Eleni Aklillu, Eliford Ngaimisi, Ferdinand Mugusi, Omary Minzi, Jürgen Burhenne, Mohammed Janabi, Philip Sasi, Leif Bertilsson, Walter E. Haefeli and Abiy Habtewold and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Sabina Mugusi

25 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sabina Mugusi Tanzania	13	364	174	150	136	119	28	602
Eliford Ngaimisi Tanzania	16	333 0.9×	153 0.9×	143 1.0×	171 1.3×	160 1.3×	22	681
Philip Sasi Tanzania	15	250 0.7×	97 0.6×	118 0.8×	135 1.0×	105 0.9×	36	774
Abiy Habtewold Ethiopia	15	361 1.0×	158 0.9×	172 1.1×	277 2.0×	116 1.0×	25	728
SH Khoo United Kingdom	15	614 1.7×	275 1.6×	200 1.3×	77 0.6×	166 1.4×	40	843
Natsuo Tachikawa Japan	16	533 1.5×	217 1.2×	284 1.9×	103 0.8×	66 0.6×	74	999
Mohammed Janabi Tanzania	9	216 0.6×	119 0.7×	81 0.5×	87 0.6×	79 0.7×	15	412
Deirdre Egan United Kingdom	15	730 2.0×	356 2.0×	199 1.3×	100 0.7×	223 1.9×	26	955
Odin Naderer United States	12	287 0.8×	109 0.6×	217 1.4×	52 0.4×	69 0.6×	32	729
Eric C. M. Van Gorp Netherlands	13	388 1.1×	148 0.9×	69 0.5×	70 0.5×	81 0.7×	17	713
Concepta Merry Ireland	12	303 0.8×	138 0.8×	72 0.5×	58 0.4×	110 0.9×	19	515

Countries citing papers authored by Sabina Mugusi

Since Specialization

Citations

This map shows the geographic impact of Sabina Mugusi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabina Mugusi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabina Mugusi more than expected).

Fields of papers citing papers by Sabina Mugusi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabina Mugusi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabina Mugusi. The network helps show where Sabina Mugusi may publish in the future.

Co-authorship network of co-authors of Sabina Mugusi

This figure shows the co-authorship network connecting the top 25 collaborators of Sabina Mugusi. A scholar is included among the top collaborators of Sabina Mugusi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabina Mugusi. Sabina Mugusi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mugusi, Sabina, et al.. (2024). CYP2B6 and ABCB1 genotypes predict methadone plasma exposure among patients on maintenance therapy against opioid addictions in Tanzania. British Journal of Clinical Pharmacology. 90(11). 2823–2836.

Rahnavard, Ali, et al.. (2024). Molecular epidemiology of pregnancy using omics data: advances, success stories, and challenges. Journal of Translational Medicine. 22(1). 106–106. 2 indexed citations

Mremi, Alex, et al.. (2023). Concomitant squamous cell carcinoma of the bladder and renal tuberculosis: A case report from northern Tanzania. SHILAP Revista de lepidopterología. 11(3). e7127–e7127. 1 indexed citations

Mugusi, Sabina, et al.. (2023). Polypharmacy and health related quality of life among older adults on antiretroviral therapy in a tertiary hospital in Tanzania: a hospital-based cross-sectional study. BMC Infectious Diseases. 23(1). 179–179. 2 indexed citations

Mugusi, Sabina, Bruno Sunguya, Philip Sasi, et al.. (2021). Effect of aspirin on HIV disease progression among HIV-infected individuals initiating antiretroviral therapy: study protocol for a randomised controlled trial. BMJ Open. 11(11). e049330–e049330. 5 indexed citations

Mugusi, Sabina, Abiy Habtewold, Eliford Ngaimisi, et al.. (2020). Impact of Population and Pharmacogenetics Variations on Efavirenz Pharmacokinetics and Immunologic Outcomes During Anti-Tuberculosis Co-Therapy: A Parallel Prospective Cohort Study in Two Sub-Sahara African Populations. Frontiers in Pharmacology. 11. 26–26. 16 indexed citations

Minzi, Omary, Sabina Mugusi, Philip Sasi, et al.. (2018). Long-term efavirenz pharmacokinetics is comparable between Tanzanian HIV and HIV/Tuberculosis patients with the same CYP2B6*6 genotype. Scientific Reports. 8(1). 16316–16316. 8 indexed citations

Mugusi, Sabina, Eliford Ngaimisi, Mohammed Janabi, et al.. (2018). Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin. European Journal of Clinical Pharmacology. 74(11). 1405–1415. 8 indexed citations

Ngaimisi, Eliford, et al.. (2018). Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania. BMC Pharmacology and Toxicology. 19(1). 66–66. 1 indexed citations

10.

Svärd, Jenny, Sabina Mugusi, Doreen Mloka, et al.. (2017). Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy. PLoS ONE. 12(6). e0178942–e0178942. 12 indexed citations

11.

Aklillu, Eleni, Abiy Habtewold, Eliford Ngaimisi, et al.. (2016). SLCO1B1 Gene Variations Among Tanzanians, Ethiopians, and Europeans: Relevance for African and Worldwide Precision Medicine. OMICS A Journal of Integrative Biology. 20(9). 538–545. 24 indexed citations

12.

Ngaimisi, Eliford, Omary Minzi, Sabina Mugusi, et al.. (2014). Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4 -hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment. Journal of Antimicrobial Chemotherapy. 69(12). 3311–3319. 24 indexed citations

13.

Aklillu, Eleni, Linda Odenthal-Hesse, Abiy Habtewold, et al.. (2013). CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans. BMC Infectious Diseases. 13(1). 536–536. 15 indexed citations

14.

Machado, Lee R., Eliford Ngaimisi, Abiy Habtewold, et al.. (2013). Copy Number Variation of Fc Gamma Receptor Genes in HIV-Infected and HIV-Tuberculosis Co-Infected Individuals in Sub-Saharan Africa. PLoS ONE. 8(11). e78165–e78165. 14 indexed citations

15.

Ngaimisi, Eliford, Abiy Habtewold, Omary Minzi, et al.. (2013). Importance of Ethnicity, CYP2B6 and ABCB1 Genotype for Efavirenz Pharmacokinetics and Treatment Outcomes: A Parallel-Group Prospective Cohort Study in Two Sub-Saharan Africa Populations. PLoS ONE. 8(7). e67946–e67946. 107 indexed citations

16.

Mugusi, Sabina, Eliford Ngaimisi, Mohamed Janabi, et al.. (2012). Liver Enzyme Abnormalities and Associated Risk Factors in HIV Patients on Efavirenz-Based HAART with or without Tuberculosis Co-Infection in Tanzania. PLoS ONE. 7(7). e40180–e40180. 53 indexed citations

17.

Ngaimisi, Eliford, Sabina Mugusi, Omary Minzi, et al.. (2011). Effect of Rifampicin and CYP2B6 Genotype on Long-Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis. Clinical Pharmacology & Therapeutics. 90(3). 406–413. 66 indexed citations

18.

Mugusi, Sabina, Julius Chacha Mwita, Joel M Francis, et al.. (2010). Effect of Improved access to Antiretroviral Therapy on clinical characteristics of patients enrolled in the HIV care and treatment clinic, at Muhimbili National Hospital (MNH), Dar es Salaam, Tanzania. BMC Public Health. 10(1). 291–291. 11 indexed citations

19.

Ngaimisi, Eliford, Sabina Mugusi, Omary Minzi, et al.. (2010). Long-Term Efavirenz Autoinduction and Its Effect on Plasma Exposure in HIV Patients. Clinical Pharmacology & Therapeutics. 88(5). 676–684. 92 indexed citations

20.

Mugusi, Ferdinand, Sabina Mugusi, M Bakari, et al.. (2009). Enhancing adherence to antiretroviral therapy at the HIV clinic in resource constrained countries; the Tanzanian experience. Tropical Medicine & International Health. 14(10). 1226–1232. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact